Cancer Research  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 6187-6192, November 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLellan, E. A.
Right arrow Articles by Bird, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLellan, E. A.
Right arrow Articles by Bird, R. P.

Aberrant Crypts: Potential Preneoplastic Lesions in the Murine Colon

Elizabeth A. McLellan and Ranjana P. Bird1

Ludwig Institute for Cancer Research Toronto Branch, Toronto, Ontario, Canada M4Y 1M4 and the Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 1A8

Murine colons treated with the colon carcinogen azoxymethane (AOM) have been reported to contain aberrant crypts (AC), which are characterized by their larger size and wider pericryptal zones. The methodology used to visualize AC consists of staining the fixed, unsectioned colonic mucosa with methylene blue and transillumination of the luminal surface at a magnification of 40x. The objective of the present studies was to determine if AC demonstrate characteristics to support our hypothesis that they are putative preneoplastic lesions. Studies were designed to determine the time of occurrence of AC (Study I), the induction of AC in response to varying dosages of AOM ranging from 0.0 to 10.0 mg/kg body weight (Study II), and the effect of a high fat diet (20% fat by weight) on the number and size of AC (Study III). In all studies 4–6-week-old female CF1 mice were used. In addition C57BL/6J female mice were used in Study I. The major findings were as follows: (a) the time period required to form AC was approximately 2 weeks following a single AOM injection (5 mg/kg); (b) a dose-dependent increase in the induction of AC was noted in response to AOM from none in the control group to a plateau level of 2.90 ± 0.38 foci at a dose of 5.0 mg/kg; (c) in comparison to the low fat group, the high fat group had a greater (P < 0.05) mean number of foci of AC per 5 cm of colon (15.67 ± 1.32 vs. 11.44 ± 1.44) and a larger (P < 0.05) mean size of foci of AC (0.0296 ± 0.0012 mm vs. 0.0249 ± 0.0012 mm) after 16 weeks on the respective diets; and (d) preliminary histological appearance of foci of AC revealed mild atypia to unequivocal dysplasia. The findings of the present study are consistent with the hypothesis that AC are putative preneoplastic lesions.

1 To whom requests for reprints should be addressed.

Received 2/18/88. Revised 7/ 6/88. Accepted 8/ 3/88.




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
P. Lance and S. R. Hamilton
Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention
Cancer Prevention Research, June 1, 2008; 1(1): 4 - 8.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Kim, J. Ng, A. Arozulllah, R. Ewing, X. Llor, R. E. Carroll, and R. V. Benya
Aberrant Crypt Focus Size Predicts Distal Polyp Histopathology
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1155 - 1162.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Vanamala, T. Leonardi, B. S. Patil, S. S. Taddeo, M. E. Murphy, L. M. Pike, R. S. Chapkin, J. R. Lupton, and N. D. Turner
Suppression of colon carcinogenesis by bioactive compounds in grapefruit
Carcinogenesis, June 1, 2006; 27(6): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al.
Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis
Cancer Res., February 1, 2005; 65(3): 887 - 897.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. E. Paulsen, E. M. Loberg, H. B. Olstorn, H. Knutsen, I.-L. Steffensen, and J. Alexander
Flat Dysplastic Aberrant Crypt Foci Are Related to Tumorigenesis in the Colon of Azoxymethane-Treated Rat
Cancer Res., January 1, 2005; 65(1): 121 - 129.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Fujiwara, M. Ochiai, T. Ohta, M. Ohki, H. Aburatani, M. Nagao, T. Sugimura, and H. Nakagama
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Carcinogenesis, August 1, 2004; 25(8): 1495 - 1505.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C.-K. Hsu, J.-W. Liao, Y.-C. Chung, C.-P. Hsieh, and Y.-C. Chan
Xylooligosaccharides and Fructooligosaccharides Affect the Intestinal Microbiota and Precancerous Colonic Lesion Development in Rats
J. Nutr., June 1, 2004; 134(6): 1523 - 1528.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama
Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine
Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara
Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis
Cancer Res., May 15, 2003; 63(10): 2388 - 2392.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. Chung, D. Wu, R. Gay, S. N. Han, B. Goldin, R. Bronson, J. Mason, D. E. Smith, and S. N. Meydani
Effect of Age on Susceptibility to Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation in C57BL/6JNIA Mice
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): B400 - 405.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Kassie, M. Uhl, S. Rabot, B. Grasl-Kraupp, R. Verkerk, M. Kundi, M. Chabicovsky, R. Schulte-Hermann, and S. Knasmuller
Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen
Carcinogenesis, February 1, 2003; 24(2): 255 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Chung, D. Wu, S. N. Han, R. Gay, B. Goldin, R. E. Bronson, J. B. Mason, D. E. Smith, and S. N. Meydani
Vitamin E Supplementation Does Not Alter Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation in Young or Old Mice
J. Nutr., February 1, 2003; 133(2): 528 - 532.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Nascimbeni, F. Donato, M. Ghirardi, P. Mariani, V. Villanacci, and B. Salerni
Constipation, Anthranoid Laxatives, Melanosis Coli, and Colon Cancer: A Risk Assessment Using Aberrant Crypt Foci
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 753 - 757.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Caderni, M.-G. Perrelli, F. Cecchini, and L. Tessitore
Enhanced growth of colorectal aberrant crypt foci in fasted/refed rats involves changes in TGF{beta}1 and p21CIP expressions
Carcinogenesis, February 1, 2002; 23(2): 323 - 327.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. P. Pretlow, R. P. Bird, Y. Yamada, Y. Hirose, A. Hara, and H. Mori
Correspondence re: Y. Yamada et al., Frequent {beta}-Catenin Gene Mutations and Accumulations of the Protein in the Putative Preneoplastic Lesions Lacking Macroscopic Aberrant Crypt Foci Appearance, In Rat Colon Carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and Sequential Analysis of Morphological and Biological Properties of {beta}-Catenin-accumulated Crypts, Provable Premalignant Lesions Independent of Aberrant Crypt Foci in Rat Colon Carcinogenesis. Cancer Res., 61: 1874-1878, 2001.
Cancer Res., October 1, 2001; 61(20): 7699 - 7701.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Ochiai, T. Ubagai, T. Kawamori, H. Imai, T. Sugimura, and H. Nakagama
High susceptibility of Scid mice to colon carcinogenesis induced by azoxymethane indicates a possible caretaker role for DNA-dependent protein kinase
Carcinogenesis, September 1, 2001; 22(9): 1551 - 1555.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Anti, A Armuzzi, S Morini, E Iascone, G Pignataro, C Coco, R Lorenzetti, M Paolucci, M Covino, A Gasbarrini, et al.
Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas
Gut, February 1, 2001; 48(2): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Y Kishimoto, N Takata, T Jinnai, T Morisawa, G Shiota, H Kawasaki, and J Hasegawa
Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane
Gut, December 1, 2000; 47(6): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F.-L. Chung, C.C. Conaway, C.V. Rao, and B. S. Reddy
Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate
Carcinogenesis, December 1, 2000; 21(12): 2287 - 2291.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Papanikolaou, Q.-S. Wang, D. Papanikolaou, H. E. Whiteley, and D. W. Rosenberg
Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis
Carcinogenesis, August 1, 2000; 21(8): 1567 - 1572.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Tessitore, A. Davit, I. Sarotto, and G. Caderni
Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression
Carcinogenesis, August 1, 2000; 21(8): 1619 - 1622.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Nagai, S. Ishizuka, H. Hara, and Y. Aoyama
Dietary Sugar Beet Fiber Prevents the Increase in Aberrant Crypt Foci Induced by {gamma}-Irradiation in the Colorectum of Rats Treated with an Immunosuppressant
J. Nutr., July 1, 2000; 130(7): 1682 - 1687.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. J. Wargovich, A. Jimenez, K. McKee, V. E. Steele, M. Velasco, J. Woods, R. Price, K. Gray, and G. J. Kelloff
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression
Carcinogenesis, June 1, 2000; 21(6): 1149 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Purewal, M. Velasco, A. J. Fretland, D. W. Hein, and M. J. Wargovich
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Induces a Higher Number of Aberrant Crypt Foci in Fischer 344 (Rapid) Than in Wistar Kyoto (Slow) Acetylator Inbred Rats
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 529 - 532.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Singh, M. Velasco, R. Given, M. Wargovich, A. Varro, and T. C. Wang
Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM
Am J Physiol Gastrointest Liver Physiol, March 1, 2000; 278(3): G390 - G399.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R Bartoli, F Fernandez-Banares, E Navarro, E Castella, J Mane, M Alvarez, C Pastor, E Cabre, and M A Gassull
Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E2 synthesis
Gut, February 1, 2000; 46(2): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. M. Fenoglio-Preiser and A. Noffsinger
Review Article: Aberrant Crypt Foci: A Review
Toxicol Pathol, November 1, 1999; 27(6): 632 - 642.
[PDF]


Home page
CarcinogenesisHome page
A. P. Soler, R.D. Miller, K. V. Laughlin, N. Z. Carp, D. M. Klurfeld, and J. M. Mullin
Increased tight junctional permeability is associated with the development of colon cancer
Carcinogenesis, August 1, 1999; 20(8): 1425 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. D. Gallaher and J. Khil
The Effect of Synbiotics on Colon Carcinogenesis in Rats
J. Nutr., July 1, 1999; 129(7): 1483 - 1483.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. J. Davies, E. A. Bowey, H. Adlercreutz, I. R. Rowland, and P. C. Rumsby
Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats
Carcinogenesis, June 1, 1999; 20(6): 927 - 931.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Ishiguro, M. Ochiai, T. Sugimura, M. Nagao, and H. Nakagama
Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility
Carcinogenesis, June 1, 1999; 20(6): 1063 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
N. R. Murray, L. A. Davidson, R. S. Chapkin, W. Clay Gustafson, D. G. Schattenberg, and A. P. Fields
Overexpression of Protein Kinase C beta II Induces Colonic Hyperproliferation and Increased Sensitivity to Colon Carcinogenesis
J. Cell Biol., May 17, 1999; 145(4): 699 - 711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.